Review of genetic and pharmacogenetic differences in cytotoxic and targeted therapies for pancreatic cancer in African Americans.

J Natl Med Assoc · 2023 · PMC10639003 · PMID 36801148

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Statistically significant polymorphisms include: DCK 2190A>T, POLA2 2089G>A, SLC28A1 1543G>A and the highly significant polymorphs were- CDA 79A>C, CDA 208G>A, DCTD 315T>C, SLC28A1 1576T>C, SLC28A2 283A>C, TYMS 1494del. 27 Wong et al reviewed genetic polymorphisms with clinical relevance for cancer patients on gemcitabine therapy.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.